Atripla and Hip joint replacement for Men aged 40-49 (a phase IV clinical study of FDA data)

Summary:

Hip joint replacement is found for men aged 40-49 who take Atripla (efavirenz; emtricitabine; tenofovir disoproxil fumarate). This study is created by eHealthMe based on reports of 3,549 men aged 40-49 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Atripla when people have Hip joint replacement
Top conditions
Top co-used drugs
Top other side effects

On Jul, 04, 2026

3,549 men aged 40-49 reported to have side effects when taking Atripla.
Among them, 48 people (1.35%) have Hip joint replacement

What is Atripla?

Atripla has active ingredients of efavirenz; emtricitabine; tenofovir disoproxil fumarate. It is often used in hiv infection. eHealthMe is studying from 36,036 Atripla users. Check the latest studies of Atripla.

What is Hip joint replacement?

Hip joint replacement is found to be associated with 861 drugs and 1,062 conditions by eHealthMe. Check the latest studies of Hip joint replacement.

Number of reports submitted per year:

Could Atripla cause Hip joint replacement in men aged 40-49?

Time on Atripla when people have Hip joint replacement *

Severity of Hip joint replacement

n/a

How people recovered from Hip joint replacement

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 4 people, 8.33%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Bone Density Decreased: 34 people, 70.83%
Bone Loss: 32 people, 66.67%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 32 people, 66.67%
Osteoporosis (bones weak and more likely to break): 23 people, 47.92%
Pain: 22 people, 45.83%
Emotional Distress: 22 people, 45.83%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 21 people, 43.75%
Chronic Kidney Disease: 19 people, 39.58%
Multiple Fractures: 17 people, 35.42%
Tooth Loss: 17 people, 35.42%

* Approximation only. Some reports may have incomplete information.

Do you take Atripla and have Hip joint replacement?

- Check whether Hip joint replacement is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Atripla and Hip joint replacement

How the study uses the data?

The study is based on (applicable) gender, age, efavirenz; emtricitabine; tenofovir disoproxil fumarate (the active ingredients of Atripla) and Atripla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.